热门资讯> 正文
内部人买入后免疫组股上涨
2025-03-26 23:16
- Immunome (NASDAQ:IMNM) stock rose about 5% after the company's Director and Chief Technology Officer disclosed share purchase.
- Philip Tsai, Chief Technology Officer, bought 12,300 shares at $8.42 per share for a value worth $1M. Tsai now holds about 33,300 shares of the company.
- Jean Jacques Bienaime, director at Immunome, bought 7,000 shares at a price of $8.21 per share for a total value of $57,470. Bienaime now holds 23,615 shares.
More on Immunome
- Immunome Can Take The Fight To Competitors With Varegacestat
- Immunome prices upsized public offering to raise $150M
- Seeking Alpha’s Quant Rating on Immunome
- Historical earnings data for Immunome
- Financial information for Immunome
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
